Bio-Techne Corporation (TECH)
Company Info
Highlights
$7.58B
$0.84
57.54
1.29
$1.21B
$796.33M
$284.25M
$45.94 - $83.21
$70.11
5.28%
3.14
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Bio-Techne Corporation (TECH) returned -32.62% year-to-date (YTD) and -37.04% over the past 12 months. Over the past 10 years, TECH returned 7.59% annually, underperforming the S&P 500 benchmark at 10.85%.
TECH
-32.62%
-3.72%
-35.59%
-37.04%
-18.94%
-5.62%
7.59%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of TECH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2.11% | -15.94% | -5.05% | -14.12% | -3.72% | -32.62% | |||||||
| 2024 | -8.86% | 4.74% | -4.32% | -10.20% | 22.24% | -7.18% | 13.87% | -9.22% | 8.03% | -7.73% | 2.29% | -4.42% | -6.25% |
| 2023 | -3.89% | -8.72% | 2.13% | 7.67% | 2.49% | -0.20% | 2.17% | -5.90% | -13.18% | -19.74% | 15.30% | 22.67% | -6.49% |
| 2022 | -27.24% | 11.51% | 3.25% | -12.32% | -2.53% | -6.25% | 11.15% | -13.80% | -14.41% | 4.32% | 15.31% | -2.48% | -35.45% |
| 2021 | 2.32% | 11.41% | 5.60% | 11.93% | -3.12% | 8.80% | 7.10% | 3.58% | -2.92% | 8.06% | -9.80% | 9.60% | 63.40% |
| 2020 | -4.35% | -9.90% | 0.39% | 18.66% | 17.83% | -0.28% | 4.20% | -7.05% | -3.03% | 1.89% | 20.29% | 4.69% | 45.40% |
| 2019 | 20.55% | 11.33% | 2.40% | 3.04% | -3.04% | 5.27% | 0.80% | -8.69% | 2.14% | 6.39% | 5.01% | 0.58% | 52.67% |
| 2018 | 8.29% | 0.98% | 6.86% | -0.09% | -0.18% | -1.58% | 8.58% | 19.84% | 6.21% | -17.83% | -3.58% | -10.35% | 12.60% |
| 2017 | -1.05% | 4.81% | -4.39% | 5.34% | 4.97% | 4.84% | -1.35% | 7.08% | -2.33% | 8.38% | 3.11% | -3.86% | 27.40% |
| 2016 | -8.12% | 4.20% | 10.11% | -1.42% | 18.29% | 2.63% | -0.31% | -6.00% | 3.94% | -5.03% | 1.64% | -2.40% | 15.77% |
| 2015 | 0.67% | 5.22% | 2.83% | -4.32% | 5.86% | -2.75% | 11.08% | -13.36% | -2.14% | -4.61% | 3.79% | -1.33% | -1.29% |
| 2014 | -4.01% | -1.89% | -3.91% | 4.61% | -1.36% | 5.44% | 0.81% | 2.69% | -2.06% | -2.67% | 0.97% | 0.86% | -1.05% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TECH is 7, meaning it’s performing worse than 93% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Bio-Techne Corporation (TECH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Bio-Techne Corporation provided a 0.66% dividend yield over the last twelve months, with an annual payout of $0.32 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.32 | $0.32 | $0.32 | $0.64 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.32 | $0.31 |
Dividend yield | 0.66% | 0.44% | 0.41% | 0.77% | 0.25% | 0.40% | 0.58% | 0.88% | 0.99% | 1.24% | 1.42% | 1.35% |
Monthly Dividends
The table displays the monthly dividend distributions for Bio-Techne Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.16 | |||||||
| 2024 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2023 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2022 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.40 | $0.00 | $0.64 |
| 2021 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2020 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2019 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2018 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2017 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2016 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2015 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.32 |
| 2014 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.08 | $0.00 | $0.31 |
Dividend Yield & Payout
Dividend Yield
Bio-Techne Corporation has a dividend yield of 0.66%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Bio-Techne Corporation has a payout ratio of 16.93%, which is below the market average. This means Bio-Techne Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Bio-Techne Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bio-Techne Corporation was 74.39%, occurring on Apr 7, 2003. Recovery took 1283 trading sessions.
The current Bio-Techne Corporation drawdown is 63.37%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -74.39% | Jul 5, 2000 | 691 | Apr 7, 2003 | 1283 | May 12, 2008 | 1974 |
| -64.68% | Sep 27, 2021 | 917 | May 21, 2025 | — | — | — |
| -52.7% | Feb 4, 1993 | 378 | Aug 4, 1994 | 264 | Aug 21, 1995 | 642 |
| -43.8% | Aug 11, 2008 | 145 | Mar 9, 2009 | 543 | May 3, 2011 | 688 |
| -38.75% | Mar 23, 1998 | 113 | Aug 31, 1998 | 77 | Dec 18, 1998 | 190 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Bio-Techne Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Bio-Techne Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 10.4% positive surprise.
Valuation
The Valuation section provides an overview of how Bio-Techne Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for TECH, comparing it with other companies in the Biotechnology industry. Currently, TECH has a P/E ratio of 57.5. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for TECH compared to other companies in the Biotechnology industry. TECH currently has a PEG ratio of 1.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TECH relative to other companies in the Biotechnology industry. Currently, TECH has a P/S ratio of 6.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TECH in comparison with other companies in the Biotechnology industry. Currently, TECH has a P/B value of 3.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |